Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge™ era
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge™ era
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 11, Issue 3, Pages 287-302
Publisher
Informa UK Limited
Online
2012-03-04
DOI
10.1586/erv.11.183
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunotherapy for Prostate Cancer: Recent Advances, Lessons Learned, and Areas for Further Research
- (2011) J. L. Gulley et al. CLINICAL CANCER RESEARCH
- Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
- (2011) L. H. Butterfield et al. CLINICAL CANCER RESEARCH
- Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
- (2011) T. M. Beer et al. CLINICAL CANCER RESEARCH
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Response definition criteria for ELISPOT assays revisited
- (2010) Z. Moodie et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy
- (2010) W. D. Stein et al. CLINICAL CANCER RESEARCH
- Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines
- (2010) Tetsuro Sasada et al. EUROPEAN JOURNAL OF CANCER
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007
- (2010) R. Sridhara et al. JNCI-Journal of the National Cancer Institute
- Sipuleucel-T
- (2010) Celestia S. Higano et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strategies to Enhance the Therapeutic Activity of Cancer Vaccines: Using Melanoma as a Model
- (2009) Neil L. Berinstein Annals of the New York Academy of Sciences
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Do We Need a Different Set of Response Assessment Criteria for Tumor Immunotherapy?
- (2009) A. Ribas et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
- (2009) D. M. Lubaroff et al. CLINICAL CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- DCVax®-Brain and DC vaccines in the treatment of GBM
- (2009) Christopher J Wheeler et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
- (2009) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma
- (2009) Lisa H. Butterfield et al. JOURNAL OF IMMUNOTHERAPY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
- (2008) Philip M. Arlen et al. JOURNAL OF UROLOGY
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Advances in Specific Immunotherapy for Prostate Cancer
- (2007) Andrea Kiessling et al. EUROPEAN UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started